Showing results (301-310 of 391) with videos related to

Sort By:
Pageof 40
Clinical Toxicology (Philadelphia, Pa.)|August 26, 2020
The effect of myocardial injury on the clinical course of snake envenomation in South KoreaJ M Moon, Y J Koo, B J Chun, et al.
Cancer Research and Treatment|December 19, 2015
Sarcoma and Sarcomatous Metaplastic Carcinoma of the BreastS H Yu, W C Noh, H Y Bang, et al.
Beneficial Microbes|February 13, 2024
Multi-strain probiotic improves subjective sleep quality with no impact on body composition, hemodynamics, and physical activityC M Kerksick, J M Moon, K E Walden, et al.
Digestive Diseases and Sciences|May 19, 2026
External Validation of Laboratory-Based Models to Assess Portal Hypertension Severity in Patients with Compensated Chronic Liver DiseaseFahad S Mohammed, Minzhi Xing, Michael Mohnasky, et al.
International Journal of Immunopharmacology|June 1, 1995
Adjuvant effect of polyadenylic.polyuridylic acid on antibody production of recombinant hepatitis B surface antigen in miceS J Park, W H Kim, K H Han, et al.
European Journal of Applied Physiology|April 27, 2022
Effects of an external pneumatic compression device vs static compression garment on peripheral circulation and markers of sports performance and recoveryJulia C Blumkaitis, Jessica M Moon, Kayla M Ratliff, et al.
Current Oncology (Toronto, Ont.)|September 26, 2025
Safety of Combination TARE and SBRT in Hepatocellular Carcinoma: A Review of Literature & Single-Center Case SeriesBahareh Gholami, Ali Afrasiabi, Andrew M Moon, et al.
Magnetic Resonance in Medicine|October 13, 2010
Superelliptical insert gradient coil with a field-modifying layer for breast imagingSung M Moon, K Craig Goodrich, J Rock Hadley, et al.
Frontiers in Nutrition|September 18, 2023
A randomized controlled trial to examine the impact of a multi-strain probiotic on self-reported indicators of depression, anxiety, mood, and associated biomarkersKylie E Walden, Jessica M Moon, Anthony M Hagele, et al.
Digestive Diseases (Basel, Switzerland)|August 25, 2020
Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric DiseaseAndrew M Moon, Stephanie E Watkins, Anna S Lok, et al.
Pageof 40